Form 4: Intuitive Surgical CEO Gary Guthart Executes Stock Option and Sells Shares Under 10b5-1 Trading Plan

Intuitive Surgical's CEO, Gary Guthart, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Gary Guthart, CEO of Intuitive Surgical, exercised non-qualified stock options to acquire 25,200 shares of common stock at a price of $59.2278 on October 30, 2024.
• On the same day, Guthart sold a total of 25,591 shares of Intuitive Surgical common stock at weighted average prices ranging from $510.5179 to $511.6343.
• These transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on April 30, 2025.
• Following these transactions, Guthart directly owns 42,370 shares and indirectly owns 1,230,984 shares through trusts.
• Guthart also indirectly owns 19,920 shares each through trusts for the benefit of his daughter and son.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports factual transactions. The use of a 10b5-1 plan suggests a planned and orderly approach to stock sales.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Future Outlook

The CEO's transactions will continue under the existing 10b5-1 trading plan until its expiration on April 30, 2025.

Industry Context

Executive stock transactions are common and closely monitored in the healthcare and technology sectors, particularly for companies like Intuitive Surgical, which is a leader in robotic-assisted surgery. These transactions can provide insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Executive compensation and stock transactions at Intuitive Surgical are likely benchmarked against peer companies in the medical device and technology industries, such as Medtronic, Stryker, and Johnson & Johnson.
• The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies to avoid accusations of insider trading.
• The vesting schedules and option grants are likely comparable to those offered by similar companies to attract and retain top talent.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders, potentially creating downward pressure on the stock price in the short term.
• Employees holding company stock or options may be sensitive to executive stock transactions, but the 10b5-1 plan mitigates concerns about insider information.

Key Dates